Aurinia Pharmaceuticals
AUPH
#4822
Rank
C$2.85 B
Marketcap
C$21.34
Share price
-1.59%
Change (1 day)
-1.55%
Change (1 year)

EPS for Aurinia Pharmaceuticals (AUPH)

EPS in 2026 (TTM): C$3.31

According to Aurinia Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C$3.43. In 2025 the company made an earnings per share (EPS) of C$3.11 an increase over its 2024 EPS that were of C$0.07166.

EPS history for Aurinia Pharmaceuticals from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$3.316.31%
2025C$3.114240%
2024C$0.07166
2022C-$1.09-46.1%
2021C-$2.0263.95%
2020C-$1.23-33.85%
2019C-$1.8673.33%
2018C-$1.07-34.78%
2017C-$1.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Regeneron Pharmaceuticals
REGN
C$67.33 1,865.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
C-$25.22-836.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
C-$2.94-185.73%๐Ÿ‡บ๐Ÿ‡ธ USA